Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie E Buring

Showing results (421-430 of 616) with videos related to

Pageof 62
Sort By:
Journal of the American Heart Association|October 26, 2022
Impact of Vitamin D3 Versus Placebo on Cardiac Structure and Function: A Randomized Clinical TrialAlvin Chandra, Michael H Picard, Shi Huang, et al.
Spine|January 17, 2007
Addition of choice of complementary therapies to usual care for acute low back pain: a randomized controlled trialDavid M Eisenberg, Diana E Post, Roger B Davis, et al.
The Journal of Nutrition|February 8, 2025
Vitamin D Supplementation, Chronic Obstructive Lung Disease and Asthma Exacerbations, and Lung Function DeclineDiane R Gold, Vincent J Carey, Craig P Hersh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2014
Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular diseaseKathryn T Hall, Christopher P Nelson, Roger B Davis, et al.
Nutrients|October 14, 2023
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease: A Novel Analysis of the VITAL Trial Using Win Ratio and Hierarchical Composite OutcomesSoshiro Ogata, JoAnn E Manson, Jae H Kang, et al.
Contemporary Clinical Trials|January 20, 2016
Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adultsDiane R Gold, Augusto A Litonjua, Vincent J Carey, et al.
Contemporary Clinical Trials|October 12, 2011
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseJoann E Manson, Shari S Bassuk, I-Min Lee, et al.
Journal of the National Cancer Institute|October 20, 2011
Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studiesFederico C F Calboli, David G Cox, Julie E Buring, et al.
Diabetologia|October 24, 2020
Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trialChristine P Limonte, Leila R Zelnick, John Ruzinski, et al.
Circulation Research|March 9, 2016
Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality RiskPatrick R Lawler, Akintunde O Akinkuolie, Paulette D Chandler, et al.
Pageof 62

Showing results (421-430 of 616) with videos related to

Sort By:
Pageof 62
Journal of the American Heart Association|October 26, 2022
Impact of Vitamin D3 Versus Placebo on Cardiac Structure and Function: A Randomized Clinical TrialAlvin Chandra, Michael H Picard, Shi Huang, et al.
Spine|January 17, 2007
Addition of choice of complementary therapies to usual care for acute low back pain: a randomized controlled trialDavid M Eisenberg, Diana E Post, Roger B Davis, et al.
The Journal of Nutrition|February 8, 2025
Vitamin D Supplementation, Chronic Obstructive Lung Disease and Asthma Exacerbations, and Lung Function DeclineDiane R Gold, Vincent J Carey, Craig P Hersh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2014
Polymorphisms in catechol-O-methyltransferase modify treatment effects of aspirin on risk of cardiovascular diseaseKathryn T Hall, Christopher P Nelson, Roger B Davis, et al.
Nutrients|October 14, 2023
Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease: A Novel Analysis of the VITAL Trial Using Win Ratio and Hierarchical Composite OutcomesSoshiro Ogata, JoAnn E Manson, Jae H Kang, et al.
Contemporary Clinical Trials|January 20, 2016
Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adultsDiane R Gold, Augusto A Litonjua, Vincent J Carey, et al.
Contemporary Clinical Trials|October 12, 2011
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseJoann E Manson, Shari S Bassuk, I-Min Lee, et al.
Journal of the National Cancer Institute|October 20, 2011
Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studiesFederico C F Calboli, David G Cox, Julie E Buring, et al.
Diabetologia|October 24, 2020
Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trialChristine P Limonte, Leila R Zelnick, John Ruzinski, et al.
Circulation Research|March 9, 2016
Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality RiskPatrick R Lawler, Akintunde O Akinkuolie, Paulette D Chandler, et al.
Pageof 62